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determined, the addition of atropine to the propranolol- 
treated heart only minimally changed the sinus cycle 
length (640 to 610 ms). This is consistent with some 
decrease in vagal effect on the sinus node. 
An alternative hypothesis is that effective sympathetic 
tone at the sinoatrial node is increased. It is possible that 
the atria1 injury produced by radiofrequency energy can 
cause the same increase in &adrenergic receptor density 
that is seen in myocardial ischemia.rr Furthermore, it is 
possible that the atria1 injury produced by the radiofre- 
quency modification procedure induces the local release 
of adrenergic neurotransmitters without producing sys- 
temically detectable levels. However, it seems unlikely 
that limited atria1 injury would produce a sustained in- 
crease in Badrenergic receptor density or sustained local 
release of neurotransmitters. 
Another potential explanation for inappropriate sinus 
tachycardia in these patients is that they had preexisting 
paroxysmal sinus tachycardia unrelated to radiofrequen- 
cy ablation, which was revealed by discontinuation of 
antiarrhythmic medications. However, this seems unlike- 
ly because: (1) no history of paroxysmal sinus tachycar- 
dia was noted before the initiation of drug therapy, and 
(2) paroxysmal sinus tachycardia is a rare disease and its 
coexistence with AVJRT seems even more improbable. 
In this report, the only technique used for AV junc- 
tional modification was the anterior or fast pathway ap- 
proach. It is not known if inappropriate sinus tachycardia 
may also develop when the posterior or slow pathway 
approach is used, nor is it known if improvements to the 
procedure will affect the development of this potential 
complication. 
Thus, 3 of 8 patients who developed symptomatic, 
inappropriate sinus tachycardia after radiofrequency cur- 
rent catheter modification of the AV node were present- 
ed. This is the first report of this complication. The symp- 
toms ranged from mild to debilitating palpitations and 
often needed treatment with @ blockers that are effective 
in controlling symptoms. It appears that in most patients 
the inappropriate sinus tachycardia may resolve over a 
prolonged time period, but may remain as a significant 
long-term problem needing treatment. It appears as if 
autonomic dysfunction may have an important role in the 
etiology of this complication; however, the role of other, 
unexplained factors cannot be excluded. Continued fol- 
low-up will be needed to establish the natural history of 
this complication, and further work is needed to elucidate 
its cause. 
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R adiofrequency catheter ablation has become the treatment of choice for selected patients with parox- 
ysmal supraventricular tachycardia due to atrioventricu- 
lar node reentry or the Wolff-Parkinson-White syn- 
drome.1-3 Despite encouraging results described in sever- 
al series, the optimal energy delivery strategy has not 
been defined. Lesion formation occurs during radiofre- 
quency ablation as the result of resistive heating at the 
electrode-tissue interface4 The magnitude of heat gener- 
ation is proportional to power density at the point of 
contact5 Electrosurgical units currently being used for 
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radiofrequency ablation have a low source impedance 
and therefore approximate constant voltage sources. 
With such a device, one preselects a given output voltage. 
Applied power is proportional to the square of this output 
voltage and is inversely proportional to the load imped- 
ance imposed by the ablation catheter, patient and indif- 
ferent electrode. Thus, the effectiveness of any given en- 
ergy application may be influenced by the impedance of 
the system. This study characterizes impedance during 
radiofrequency catheter ablation in humans, and defines 
the relation between clinical and ablation parameters, 
and measured impedance. 
Twenty-seven patients (15 men [55%], mean age 42 
f 19 years) undergoing radiofrequency catheter abla- 
tion in July and August 1991 were included in this study. 
The procedure was performed using a protocol apprwed 
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TABLE I Characteristics of Patients Undergoing Radio- 
frequency Catheter Ablation 
Age (yr) Heart 
Patient & Sex Disease Diagnosis Ablation Site 
1 15F 0 WPW Right posteroseptal 
2 17F 0 WPW Right anteroseptal 
3 17M 0 WPW Left posterolateral 
4 18M 0 WPW Right posteroseptal 
5 19M 0 WPW Left lateral 
6 19F 0 WPW Mid-septal 
7 26F 0 WPW Right posteroseptal 
8 30F 0 WPW Right posteroseptal 
9 32M 0 WPW Right anteroseptal 
10 33F 0 WPW Left lateral 
11 38M 0 WPW Left posterolateral 
12 38M 0 WPW Left lateral 
13 41M 0 WPW Right anterolateral 
14 41F 0 WPW Right anteroseptal 
15 46M 0 AVNRT Fast pathway 
16 47F 0 AVNRT Slow pathway 
17 48M 0 AVNRT Slow pathway 
18 49M 0 WPW Left anterior 
19 55M 0 WPW Left posteroseptal 
20 56F 0 WPW Right anteroseptal 
21 65F 0 WPW Right anteroseptal 
22 66F 0 AVN ablation His bundle 
23 70M 0 WPW Left lateral 
24 52M CAD AVN ablation His bundle 
25 59M CAD:CABG AVN ablation His bundle 
26 67F CAD AVNRT Fast pathway 
27 72M CAD:CABG VT Left ventricle 
AVN = atrioventricular node; AVNRT = atrioventricular nodal reentrant tachycardia; 
CABG = coronary artery bypass graft; CAD = coronary artery disease: VT = ventricular 
tachycardia; WPW = Wolff-Parkinson-Whitesyndrome. 
by the human research committee of the University of 
Michigan Medical Center, and all patients gave in- 
formed written consent. Clinical characteristics of this 
cohort are listed in Table I. Structural heart disease was 
present in 4 patients. Catheter ablation of an accessory 
atrioventricular connection was performed in 19 pa- 
tients, ablation of the atrioventricular junction in 3, and 
attioventricular nodal modificationfor treatment of typ- 
ical atriwentricular node reentry tachycardia in 4. Pa- 
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tient 21 had an attempt at ablation of microreentrant 
ventricular tachycardia in the inferobasilar aspect of the 
left ventricle. 
The power source used in this study supplied a con- 
tinuous, unmodulated output at 500 KHz (EP Technol- 
ogies, Inc., Mountain View, Cahfornia). This device, 
through an interface with a microcomputer (T-1600, 
Toshiba Electronics, Japan), measures, displays and 
stores root-mean-square voltage, current, power and im- 
pedance during each energy application. To prevent con- 
tinued currentflow after coagulumformation, the device 
automatically discontinues power delivery if impedance 
is >300 ohms. 
Electrode catheters from 2 manufacturers (Mans- 
field Scientific, Watertown, Massachusetts, and EP 
Technologies) were used for ablation. Both catheters 
had deflectable shafts that were 7Fr in diameter, as well 
as large (4 mm in length) distal electrodes. Radiofre- 
quency energy was applied between the distal electrode 
of the ablation catheter and a large surface area adhesive 
skin electrode (Valleylab, Boulder, Colorado) placed 
wer the left scapula. Techniques for positioning the ab- 
lation catheter were described previously.1*3*6 For inter- 
ruption of atriwentricular conduction, the catheter was 
advanced across the tricuspid annulus and manipulated 
to record the largest His electrogram. Ablation of right 
free wall and septal accessory pathways was performed 
by introducing the catheter in the femoral vein andposi- 
tioning it at a site on the tricuspid annulus with a short 
local atriwentricular or ventriculoatrial activation time, 
or both. A retrograde aortic approach was used for left 
free wall accessory pathways. The catheter was posi- 
tioned on the ventricular side of the mitral annulus at the 
site of earliest activation. 
The location of the ablation catheter, energy delivery 
parameters (including voltage, current, power, duration 
and impedance) and electrophysiologic effects of every 
radiofrequency application were recorded in all 27 sub- 
jects. To determine if impedance was influenced by the 
size of the patient, body surface area was calculated for 
each patient using the formula of Dubois.7 To define the 
relation between lung volumes and impedance, forced 
vital capacity was measured within 24 hours of catheter 
ablation in 18 subjects using a precision handheld spi- 
rometer (Boehringer Laboratories, Germany). 
The relation between clinical and ablation parame- 
ters, and impedance was analyzed using multivariate 
regression. A value <0.05 was considered statistically 
significant. 
In all, 257 applications of radiofrequency energy 
were delivered during the course of catheter ablation in 
the 27 patients. Mean impedance was 100 f 10 ohms 
(range 77 to 132). There was a significant, direct correla- 
tion between body surface area and impedance (9 = 
0.44, p = 0.0001; Figure 1). Forced vital capacity was 
also independently predictive of impedance (r* = 0.39, p 
= 0.03). 
Neither age nor gender correlated with impedance. 
Impedance during applications that produced conduc- 
tion block was slightly but significantly less than during 
ineffective applications (98 f 9 us 101 f 10 ohms; 
p = 0.01). Applied power did not appear to affect im- 
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pedance, nor was there a difference in impedance be- 
tween applications in the right heart and those in the left, 
nor between the 2 types of ablation catheter used. 
Impedance during radiofrequency catheter ablation 
in humans is variable, with a range of 55 ohms noted in 
this study. Impedance was directly proportional to body 
surface area and forced vital capacity. Impedance was 
significantly less during radiofrequency applications that 
were successful compared with during ineffective appli- 
cations. No other clinical or energy delivery parameters 
appeared to affect impedance, nor did the 2 types of 
ablation catheters used in this study differ significantly. 
The volume of a resistive medium interposed between 
2 electrodes is proportional to the impedance to altemat- 
ing current flow. The larger the body surface area, the 
greater the amount of tissue between the ablating and 
indifferent skin electrodes. The relation between body 
size and transthoracic impedance during defibrillation8 is 
consistent with this hypothesis. 
A study of radiofrequency ablation in the left ventricle 
in experimental animals showed significantly higher im- 
pedances when a conventional distal electrode (2 mm in 
length, 12.6 mm2 in surface area) was used compared 
with a large distal one (3 mm in length, 18.9 mm* in 
surface area).9 The similar mean impedance values seen 
with the 2 different types of ablation catheter in the 
current study probably reflect the fact that distal elec- 
trode surface areas were the same. 
Impedance during successful radiofrequency energy 
applications was slightly but significantly lower than dur- 
ing unsuccessful applications. Studies in animals, and a 
recent clinical report from our laboratory show that tissue 
heating causes impedance to decrease.iO This tempera- 
ture dependence may also explain why effective applica- 
tions were associated with a lower mean impedance, be- 
cause some ineffective applications may have been the 
result of inadequate heating. 
It is well known that phasic changes in lung volume 
with respiration produce corresponding fluctuations in 
transthoracic impedance. This phenomenon has been 
used to estimate minute ventilation in activity pacemak- 
ers, and for apnea monitoring with cutaneous elec- 
trodes.’ i-l3 The influence of vital capacity seen in this 
study suggests that the volume of lung parenchyma be- 
tween the endocardial and indifferent electrodes also sig- 
nificantly affects impedance to current flow during radio- 
frequency catheter ablation. 
The results of this study suggest that the size of the 
patient can significantly affect impedance during radio 
frequency ablation, which may in turn impact on the 
adequacy of lesion formation. For example, 60 V applied 
to a small patient in whom the impedance is 90 ohms 
would result in delivery of 40 W. In contrast, 60 V applied 
in a larger patient in whom the impedance is 120 ohms 
would result in delivery of only 30 W. Therefore, if a 
constant voltage radiofrequency generator is used for 
catheter ablation, the output voltage may need adjust- 
ment commensurate with the impedance of the patient. 
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